Use of IL-18 inhibitors for the treatment and/or prevention of atherosclerosis
Details for Australian Patent Application No. 2005211606 (hide)
International Classifications
Event Publications
6 October 2005 Application Open to Public Inspection
Published as AU-B-2005211606
6 October 2005 Complete Application Filed
22 February 2007 Application Accepted
Published as AU-B-2005211606
21 June 2007 Standard Patent Sealed
14 January 2010 Assignment Registered
Applied Research Systems ARS Holding N.V.; INSERM - Institut National de la Sante et de la Recherche Medicale The patent has been assigned to INSERM - Institut National de la Sante et de la Recherche Medicale; Merck Serono SA Assignments Registered
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005211607-A gaming system with spending control and a method of gaming with controlled spending
2005211605-Method and device for protecting interferometric modulators from electrostatic discharge
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser